You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re
SBC: Apogee Biotechnology Corporation Topic: 102DESCRIPTION provided by applicant Diffuse large B cell lymphoma DLBCL represents one of the most common variants of Non Hodgkinandapos s lymphoma NHL and oncogenic herpesviruses EBV and KSHV are the etiologic agents for the majority of these tumors in patients over or those infected with the human immunodeficiency virus HIV Despite modest improvements in outcomes for patients rece ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Slip Flow Chromatography
SBC: BIOVIDRIA, INC. Topic: 100DESCRIPTION provided by applicant The goal of this STTR Phase II collaboration between Purdue University and bioVidria Inc is to commercialize disruptive new technology for protein chromatography and then maximize its impact by serving the fastest growing segment of the pharmaceutical industry protein drugs The product is a reversed phase chromatography column that uses silica particles of ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Commercialization of a Diagnostic test for amyotrophic lateral sclerosis (ALS)
SBC: IRON HORSE DIAGNOSTICS, INC. Topic: 101DESCRIPTION provided by applicant Amyotrophic lateral sclerosis ALS or Lou Gehrigandapos s disease is a fatal neurodegenerative disease with a typical lifespan of years after diagnosis The initial symptoms can be similar to many other neurologic disorders and often begin with limb weakness muscle fasciculations or increasing difficulties in speech or breathing No definitive diagnost ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
RADIOGRAPHIC CONTRAST TO DIFFERENTIATE CAVITATED FROM NON-CAVITATED DENTAL CARIES
SBC: FIREFLY HEALTH INNOVATIONS NE, INC. Topic: NIDCRDESCRIPTION provided by applicant This project aims to improve the accuracy of tests for early tooth decay dental caries specifically for interproximal surfaces where the posterior teeth abut one another In these regions there is no physical space to visually inspect or probe for caries Instead dentists rely on bitewing X rays BWs But dentists cannot tell whether lucencies observed ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Developing Intravesical Liposomes for Interstitial Cystitis
SBC: Lipella Pharmaceuticals Inc. Topic: NIDDKDESCRIPTION (provided by applicant): Lipella Pharmaceuticals Inc. (Pittsburgh, PA) is a clinical-stage pharmaceutical company specializing in intravesical therapies for urinary bladder dysfunctions. Lipella is submitting a research proposal to the Small Business Technology Transfer program titled Developing Intravesical Liposomes for Interstitial Cystitis . The project proposes to evaluate the sa ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Developing Intravesical Liposomes for Interstitial Cystitis
SBC: Lipella Pharmaceuticals Inc. Topic: NIDDKDESCRIPTION provided by applicant Lipella Pharmaceuticals Inc Pittsburgh PA is a clinical stage pharmaceutical company specializing in intravesical therapies for urinary bladder dysfunctions Lipella is submitting a research proposal to the Small Business Technology Transfer program titled andquot Developing Intravesical Liposomes for Interstitial Cystitisandquot The project proposes to e ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
